| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 04/07/1993 | EP0535039A1 Novel bacteriocin from a strain of lactococcus lactis subsp. cremoris |
| 04/07/1993 | EP0534988A1 Inhibitors of factor xii activation and applications thereof |
| 04/07/1993 | EP0366728B1 Polypeptides with fibronectin activity |
| 04/07/1993 | EP0233936B1 Synthetic polypeptides for detecting mycobacterial infections |
| 04/06/1993 | US5200510 Utilizing a preferential binding peptide bound to an insoluble matrix; elution; collection |
| 04/06/1993 | US5200505 R106 compounds |
| 04/06/1993 | US5200504 Metallopeptides having stabilized secondary structures |
| 04/06/1993 | US5200397 Administering an oligopeptides anticoagulants or wound healing agents |
| 04/06/1993 | US5200394 Derivatives of type a and b synergimycins |
| 04/01/1993 | WO1993006247A1 Hepatitis c assay |
| 04/01/1993 | WO1993006133A1 Immunoassay for identifying alcoholics and monitoring alcohol consumption |
| 04/01/1993 | WO1993006132A1 Modified peptide derivatives |
| 04/01/1993 | WO1993006129A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 04/01/1993 | WO1993006121A1 Method of synthesizing diverse collections of oligomers |
| 04/01/1993 | WO1993005812A1 Method to induce cytotoxic t lymphocytes specific for a broad array of hiv-1 isolates using hybrid synthetic peptides |
| 04/01/1993 | WO1993005802A1 Biologically active amphiphilic peptide compositions and uses therefor |
| 04/01/1993 | CA2119013A1 Hepatitis c assay |
| 04/01/1993 | CA2118939A1 Biologically active amphiphilic peptide compositions and uses thereof |
| 04/01/1993 | CA2118806A1 Method of synthesizing diverse collections of oligomers |
| 04/01/1993 | CA2118595A1 Modified peptide derivatives |
| 04/01/1993 | CA2115566A1 Polypeptide inhibitor of the replication of hsu and similar viruses |
| 03/31/1993 | EP0534618A2 Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus |
| 03/31/1993 | EP0534615A2 HLA-restricted hepatitis B virus CTL epitopes |
| 03/31/1993 | EP0534102A1 Human cytomegalovirus specific peptides and use thereof |
| 03/31/1993 | EP0533795A1 Composition of and treatment with biologically active peptides having d-amino acid residues |
| 03/31/1993 | EP0438566A4 Therapeutic peptides |
| 03/31/1993 | CN1070344A Composition for sustained and controlled release of medicamentous substances and process for preparing same |
| 03/30/1993 | US5198533 Decapeptides |
| 03/30/1993 | US5198425 Inhibitors of bacterial ribonucleotide reductase |
| 03/30/1993 | US5198421 Phosphorylated cyclic lipopeptide |
| 03/30/1993 | US5197973 Polypeptide |
| 03/30/1993 | CA1315482C Process for reducing methionine sulfoxide residues |
| 03/30/1993 | CA1315481C Synthetic polypeptides and antibodies related to epstein-barr virus early antigen-diffuse |
| 03/30/1993 | CA1315480C Phosphopeptides |
| 03/30/1993 | CA1315229C Chromatographic purification process |
| 03/30/1993 | CA1315225C Polypeptide useful for the allevation, treatment and diagnosis of auto-immune diseases, especially arthritic conditions, etc. |
| 03/24/1993 | EP0533433A1 Use of rapamycin for the manufacture of a medicament for the treatment of immunoinflammatory diseases |
| 03/24/1993 | EP0533226A2 Novel chromophore containing compounds |
| 03/24/1993 | EP0533199A2 Application to a chimeric antibody directed against ganglioside GD3 |
| 03/24/1993 | EP0532979A2 Peptides for the preparation of means for diagnosis and therapy of systemic lupus |
| 03/24/1993 | EP0532716A1 New synthethic peptides with imunomodulating activity and preparation thereof |
| 03/24/1993 | EP0532695A1 Immunochemical localization of heparanase in mouse and human melanomas |
| 03/24/1993 | EP0532693A1 1,4-diamino-2,3-dihydroxybutanes |
| 03/24/1993 | EP0532650A1 Method of inducing plant defense mechanisms. |
| 03/24/1993 | EP0345315B1 Ps2 protein derivative |
| 03/24/1993 | EP0180603B1 Rotavirus |
| 03/23/1993 | US5196511 Peptides and antibodies that inhibit integrin-ligand binding |
| 03/23/1993 | US5196404 Inhibitors of thrombin |
| 03/23/1993 | US5196319 Primary biliary cirrhosis autoantigen |
| 03/23/1993 | CA1315042C2 Methods and compositions for preparation of the tetrapeptide, h-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315041C2 Methods and compositions for preparation of the tetrapeptide, alpha-t-x-omega-u-z-y-tyr-r' |
| 03/23/1993 | CA1315040C2 Methods and compositions for preparation of the pentapeptide, alpha-t-omega-t' -arg-x-omega-u-z-y-tyr-r' |
| 03/18/1993 | WO1993005150A1 Collagen-induced platelet aggregation inhibitor |
| 03/18/1993 | WO1993005071A1 INTERLEUKIN 1β PROTEASE AND INTERLEUKIN 1β PROTEASE INHIBITORS |
| 03/18/1993 | WO1993005070A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | WO1993005011A1 Novel immunosuppressants |
| 03/18/1993 | WO1993004702A1 Use of gentisic acid or gentisyl alcohol for stabilising radiolabeled peptides and proteins |
| 03/18/1993 | WO1992020711A3 Lhrh antagonists and intermediate products |
| 03/18/1993 | CA2118695A1 Peptide inhibitors of inflammation mediated by selectins |
| 03/18/1993 | CA2117174A1 Collagen-induced platelet aggregation inhibitor |
| 03/17/1993 | EP0532466A2 Derivatives of 5-amino-4-hydroxy-hexanoic acid and their therapeutical use |
| 03/17/1993 | EP0532043A2 Factor Xa linker DNA |
| 03/17/1993 | EP0531461A1 Biologically active peptides containing d-2-alkyltryptophan. |
| 03/17/1993 | EP0531342A1 Cyclized and linear therapeutic peptides |
| 03/17/1993 | EP0495836B1 Dye transfer inhibition |
| 03/16/1993 | US5194586 Adult T Cell Leukemia Associated Antigen |
| 03/16/1993 | US5194585 Vasoactive peptides |
| 03/16/1993 | US5194392 Method of determining mimotopes |
| 03/16/1993 | US5194377 Antibiotic agent |
| 03/16/1993 | CA1314656C Analogs of gonadoliberin with improved solubility, methods for their preparation, agents containing them and their use |
| 03/13/1993 | CA2077948A1 Further novel 5-amino-4-hydroxyhexanoic acid derivatives as therapeutic agents |
| 03/10/1993 | EP0531080A2 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene protein |
| 03/10/1993 | EP0530937A1 Collagen-induced platelet aggregation inhibitor |
| 03/09/1993 | US5192746 Cyclic cell adhesion modulation compounds |
| 03/05/1993 | CA2077322A1 Peptide inhibitors of human papilloma virus protein binding to retinoblastoma gene proteins |
| 03/04/1993 | WO1993004373A1 Calcium receptor active molecules |
| 03/04/1993 | WO1993004205A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 03/04/1993 | WO1993004079A1 Method for generating and screening useful peptides |
| 03/04/1993 | WO1993003764A1 Hla-restricted hepatitis b virus ctl epitopes |
| 03/04/1993 | WO1993003753A1 Peptides for inducing cytotoxic t-lymphocyte responses to hepatitis b virus |
| 03/04/1993 | WO1993003752A1 Decapeptide having dopamine stimulating activity |
| 03/04/1993 | WO1993003748A1 Modulation of blood pressure and inhibition of platelet activation with kininogen fragment |
| 03/04/1993 | CA2116013A1 Method for generating and screening useful peptides |
| 03/04/1993 | CA2115923A1 Monoclonal antibodies to putative hcv e2/ns1 proteins and methods for using same |
| 03/03/1993 | EP0529504A2 Apparatus for the simultaneous synthesy of different peptides |
| 03/03/1993 | EP0529499A1 Compositions for topical administration to the nose or the eyes containing bradykinin antagonists |
| 03/03/1993 | EP0529075A1 Hybrid calcitonin |
| 03/03/1993 | EP0529033A1 Nucleotide sequences coding for alpha chain variable regions in human lymphocyte receptors and applications thereof |
| 03/03/1993 | EP0529031A1 Improved inhibitors of thrombin |
| 03/03/1993 | EP0529023A1 Therapeutically useful peptides and peptides fragments |
| 03/03/1993 | EP0528891A1 Method for increasing blood-brain barrier permeability |
| 03/03/1993 | EP0528861A1 Composition and treatment with biologically active peptides and toxic cations |
| 03/03/1993 | EP0528854A1 Fluorogenic peptides and their use in the determination of enzymatic activities. |
| 03/03/1993 | EP0528835A1 Cyclic peptides and their use |
| 03/03/1993 | EP0528820A1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase. |
| 03/02/1993 | US5190921 Amino acids and peptides having a modified tyrosine residue, their preparation and their application as medicaments |
| 03/02/1993 | US5190920 Method for using synthetic analogs of thrombospondin for inhibiting metastasis activity |
| 02/27/1993 | WO1993004080A1 Pseudopentapeptides with immunomodulating activity |
| 02/27/1993 | CA2094822A1 Pseudopentapeptides with immunomodulating activity |
| 02/25/1993 | DE4127790A1 New oligopeptide(s) and metal complexes - used in skin-care cosmetics |